Approach to the Patient with Drug Allergy

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 405-418

  Schnyder, Benno ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diagnosis; Drug allergy; Immediate hypersensitivity; Nonimmediate type hypersensitivity; Pseudoallergy; Therapy

Indexed keywords

ABACAVIR; ADRENALIN; ALLOPURINOL; AMINOPENICILLIN; AMINOPHENAZONE; ANTIHISTAMINIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CEPHALOSPORIN DERIVATIVE; CYCLOSPORIN; DAPSONE; DIPYRONE; DIURETIC AGENT; GLUCOCORTICOID; HEPARIN; HLA ANTIGEN; HLA B ANTIGEN; HYDRALAZINE; IMMUNOGLOBULIN E; LAMOTRIGINE; LEVODOPA; METHYLDOPA; MINOCYCLINE; NEVIRAPINE; PHENYTOIN; PROCAINAMIDE; QUININE; SULFONAMIDE; TRYPTASE; UNINDEXED DRUG;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ALLERGY TEST; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; AWARENESS; CLINICAL FEATURE; DESENSITIZATION; DIAGNOSTIC TEST; DRESS SYNDROME; DRUG ERUPTION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; GENETIC ASSOCIATION; HEMOLYTIC ANEMIA; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IN VITRO STUDY; LABORATORY TEST; LEUKOPENIA; LUPUS LIKE SYNDROME; MACULOPAPULAR RASH; PATIENT CARE; PRIORITY JOURNAL; PROVOCATION TEST; RASH; REVIEW; SERUM SICKNESS; SKIN TEST; STEVENS JOHNSON SYNDROME; SYMPTOM; THROMBOCYTOPENIA; TIME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ANAPHYLAXIS; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; HERPESVIRIDAE INFECTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEPHRITIS, INTERSTITIAL; PATIENT CARE; SKIN TESTS; VASCULITIS;

EID: 67649234565     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.005     Document Type: Review

References (50)

1. Gomes E.R., and Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5 (2005) 309-316
2. Rawlins M., and Thompson W. Mechanisms of adverse drug reactions. In: Davies D. (Ed). Textbook of adverse drug reactions (1991), Oxford Press, New York 18-45
3. Greenberger P.A. Drug allergy. J Allergy Clin Immunol 117 Suppl 2 Mini-Primer (2006) 464-470
4. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization 2003. J Allergy Clin Immunol 113 (2004) 832-836
5. Chung W.H., Hung S.I., and Chen Y.T. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7 4 (2007) 317-323
6. Bircher A.J. Symptoms and danger signs in acute drug hypersensitivity. Toxicology 209 (2005) 201-207
7. El-Shanawany T., Williams P.E., and Jolles S. Clinical immunology review series: an approach to the patient with anaphylaxis. Clin Exp Immunol 153 (2008) 1-9
8. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 (2002) 240-262
9. Ellis A.K., and Day J.H. Diagnosis and management of anaphylaxis. Can Med Assoc J 169 (2003) 307-311
10. Weiss M.E., and Adkinson N.F. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 107 (1987) 204-215
11. Chung C.H., Mirakhur B., Chan E., et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358 11 (2008) 1109-1117
12. Harboe T., Johansson S.G., Florvaag E., et al. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents. Allergy 62 12 (2007) 1445-1450
13. Kvedariene V., Martins P., Rouanet L., et al. Diagnosis of iodinated contrast media hypersensitivity: results of a 6-year period. Clin Exp Allergy 36 8 (2006) 1072-1077
14. Ebo D.G., Fisher M.M., Hagendorens M.M., et al. Anaphylaxis during anaesthesia: diagnostic approach. Allergy 62 (2007) 471-487
15. Fiszenson-Albala F., Auzerie V., Mahe E., et al. 6-Month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 149 5 (2003) 1018-1022
16. Lee A.Y. Fixed drug eruptions: incidence, recognition, and avoidance. Am J Clin Dermatol 1 5 (2000) 277-285
17. Hausermann P., Harr T., and Bircher A.J. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?. Contact Dermatitis 51 (2004) 297-310
18. Britschgi M., Steiner U.C., Schmid S., et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107 (2001) 1433-1441
19. Roujeau J., Bioulac-Sage P., and Bourseau C. Acute generalized exanthematous pustulosis: analysis of 63 cases. Arch Dermatol 127 (1991) 1333-1338
20. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
21. French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergol Int 55 (2006) 9-16
22. Knowles S.R., Shapiro L.E., and Shear N.H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf 21 (1999) 489-501
23. Peyrière H., Dereure O., Breton H., et al. Network of the French Pharmacovigilance Centers. Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist?. Br J Dermatol 155 2 (2006) 422-428
24. Shiohara T., Inaoka M., and Kano Y. Drug induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesvirus and antiviral and antidrug immune responses. Allergol Int 55 (2006) 1-8
25. Spanou Z., Keller M., Britschgi M., et al. Involvement of drug-specific T cells in acute drug-induced interstitial nephritis. J Am Soc Nephrol 17 10 (2006) 2919-2927
26. Sarzi-Puttini P., Atzeni F., Capsoni F., et al. Drug-induced lupus erythematosus. Autoimmunity 38 7 (2005) 507-518
27. Doyle M.K., and Cuellar M.L. Drug-induced vasculitis. Expert Opin Drug Saf 2 (2003) 401-409
28. Pruss A., Salama A., Ahrens N., et al. Immune hemolysis: serological and clinical aspects. Clin Exp Med 3 2 (2003) 55-64
29. Brockow K., and Romano A. Skin tests in the diagnosis of drug hypersensitivity reactions. Curr Pharm Des 14 27 (2008) 2778-2791
30. Torres J., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58 10 (2003) 961-972
31. Romano A., Blanca M., Torres M.J., et al. Diagnosis of nonimmediate reactions to β-lactam antibiotics. Allergy 59 11 (2004) 1153-1160
32. Torres M.J., Romano A., Mayorga C., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 56 9 (2001) 850-856
33. Sanz M.L., Gamboa P.M., Garcia-Aviles C., et al. Drug hypersensitivities: which room for biological tests?. Eur Ann Allergy Clin Immunol 37 (2005) 230-235
34. Nizankowska-Mogilnicka E., Bochenek G., Mastalerz L., et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 62 10 (2007) 1111-1118
35. Barbaud A., Concalo M., Bruynzeel D., et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 45 6 (2001) 321-328
36. Kano Y., Hirahara K., Mitsuyama Y., et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62 (2007) 1439-1444
37. Evans C., and Tippins E. Emergency treatment of anaphylaxis. Accid Emerg Nurs 13 4 (2005) 232-237
38. Ewan P.W. Anaphylaxis. Br Med J 316 (1998) 1442-1445
39. Ghislain P.D., and Roujeau J.C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 8 (2002) 5
40. Karaun S.H., and Jonkman M.F. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol 87 2 (2007) 144-148
41. Mittmann N., Chan B.C., Knowles S., et al. IVIG for the treatment of toxic epidermal necrolysis. Skin Therapy Lett 12 1 (2007) 7-9
42. Kelkar P.S., and Li J.T. Cephalosporin allergy. N Engl J Med 345 (2001) 804-809
43. Sodhi M., Axtell S.S., Callahan J., et al. Is it safe to use carbapenems in patients of allergy to penicillin?. J Antimicrob Chemother 54 (2004) 1155-1157
44. Mauri-Hellweg D., Zann M., Frei E., et al. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics. J Immunol 157 (1996) 1071-1079
45. Brackett C.C. Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group. Pharmacotherapy 24 7 (2004) 856-870
46. Strom B.L., Schinnar R., Apter A.J., et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 349 (2003) 1628-1635
47. Lerch M., Keller M., Britschgi M., et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 119 6 (2007) 1529-1536
48. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 6 (2006) 476-481
49. Solensky R. Drug desensitization. Immunol Allergy Clin North Am 24 (2004) 425-443
50. Stevenson D.D. Aspirin and NSAID sensitivity. Immunol Allergy Clin North Am 24 3 (2004) 491-505